Lei Cao | Hematology | Best Research Article Award

Published on by Best Achievements

Dr. Lei Cao | Hematology | Best Research Article Award

Dr. Lei Cao, The First Affiliated Hospital of Nanjing Medical University, China.

Dr. Lei Cao ๐ŸŽ“, Deputy Chief Physician, Masterโ€™s Supervisor, and Lecturer at The First Affiliated Hospital of Nanjing Medical University, specializes in malignant lymphomas and lymphoproliferative disorders ๐Ÿ”ฌ. She has led multiple national research projects, published in top-tier journals ๐Ÿ“š, and received prestigious awards and scholarships ๐Ÿ…. With a strong focus on individualized treatment and prognostic stratification, Dr. Cao is advancing cancer care and research globally ๐ŸŒ.

๐ŸŒŸ Professional Profile

Orcid Profile

๐Ÿง  Early Academic Pursuits

Dr. Lei Cao began her academic journey with a passion for hematology and oncology, pursuing rigorous medical education that laid the foundation for her specialization in malignant lymphomas and lymphoproliferative disorders. Her early focus on precise prognostic stratification and individualized treatments set the tone for a career rooted in clinical excellence and scientific inquiry.

๐Ÿ’ผ Professional Endeavors

Currently serving as Deputy Chief Physician, Master’s Supervisor, and Lecturer at the First Affiliated Hospital of Nanjing Medical University, Dr. Cao is a dynamic force in clinical medicine and medical education. She is actively involved in mentoring graduate students while maintaining a busy clinical and research schedule.

๐Ÿ”ฌ Contributions and Research Focus On Hematologyย 

Dr. Cao’s research focuses on T-cell, B-cell, NK/T-cell, and Hodgkin lymphomas, with an emphasis on improving patient survival and quality of life through personalized medicine. She has led several national and institutional research projects, notably as Principal Investigator on prestigious grants such as the National Natural Science Foundation of China Youth Project and the Bethune Medical Science Research Foundation.

Her research outputs address topics like immunosuppressive microenvironments, hepatitis B reactivation in lymphoma patients, and novel chemotherapy strategies. She has authored multiple peer-reviewed SCI-indexed journal articles, furthering insights into the biology and treatment of hematologic malignancies

๐ŸŒ Impact and Influence

Dr. Caoโ€™s work has directly contributed to clinical protocols, particularly in the treatment of indolent and relapsed lymphomas. Her clinical innovations and data-driven treatment strategies are helping to personalize therapies for patients across China. As a reviewer for journals such as Frontiers in Oncology and Cancer Medicine, she helps maintain the integrity of scientific research globally.

๐Ÿ“š Academic Citations

With a citation index of 419, her work demonstrates growing international recognition, showcasing the impact of her findings on clinical and academic communities alike.

๐Ÿ† Awards and Honors

Dr. Lei Caoโ€™s accolades include:

  • ๐Ÿฅ‡ First Prize, 2022 Jiangsu Anti-Cancer Association

  • ๐Ÿฅ‰ Third Prize, 2023 Clinical Research Innovation Award, Jiangsu Ruihua Charity Foundation

  • ๐ŸŒ Jiangsu Government Study Abroad Scholarships (2020 & 2023)

  • ๐Ÿ‘ฉโ€๐Ÿ”ฌ 2019 CSCO 35 Under 35 Most Promising Young Oncologist

  • ๐ŸŽ“ Multiple National Scholarships

๐Ÿงช Patents and Publications

 

  • ๐Ÿ“„ Patent: ZL202121517226.0 (National Utility Patent)

  • ๐Ÿ“ฐ Authored numerous high-impact publications in journals such as Blood Cancer Journal, British Journal of Haematology, Annals of Medicine, and Cancer Science.

๐Ÿ”ฎ Legacy and Future Contributions

Looking ahead, Dr. Lei Cao aims to refine stratification models, enhance targeted therapies, and further promote patient-centric care in hematologic malignancies. Her leadership, both in research and mentorship, continues to inspire a new generation of oncologists and researchers. Her future endeavors promise to deepen the scientific understanding of lymphoma biology and expand access to innovative treatments.

๐Ÿ“šPublications Top Notes

๐Ÿ“˜ Title: Stratified management based on surface antibody for the prevention of hepatitis B virus reactivation in lymphoma patients

๐Ÿ“š Journal: British Journal of Haematology
๐Ÿ“… Year: 2023
๐Ÿงช๐Ÿฉธ๐Ÿ›ก๏ธ (Oncology, Haematology, Immunity)

๐Ÿ“˜ Title: Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma

๐Ÿ“š Journal: Blood Cancer Journal
๐Ÿ“… Year: 2025
๐Ÿง ๐Ÿงฌ๐Ÿ’‰ (Oncology, Hematology, CNS)

 

Lei Cao | Hematology | Best Research Article Award

Published on by Best Achievements

Dr. Lei Cao | Hematology | Best Research Article Award

Dr. Lei Cao, The First Affiliated Hospital of Nanjing Medical University, China.

Dr. Lei Cao ๐ŸŽ“, Deputy Chief Physician, Masterโ€™s Supervisor, and Lecturer at The First Affiliated Hospital of Nanjing Medical University, specializes in malignant lymphomas and lymphoproliferative disorders ๐Ÿ”ฌ. She has led multiple national research projects, published in top-tier journals ๐Ÿ“š, and received prestigious awards and scholarships ๐Ÿ…. With a strong focus on individualized treatment and prognostic stratification, Dr. Cao is advancing cancer care and research globally ๐ŸŒ.

๐ŸŒŸ Professional Profile

Orcid Profile

๐Ÿง  Early Academic Pursuits

Dr. Lei Cao began her academic journey with a passion for hematology and oncology, pursuing rigorous medical education that laid the foundation for her specialization in malignant lymphomas and lymphoproliferative disorders. Her early focus on precise prognostic stratification and individualized treatments set the tone for a career rooted in clinical excellence and scientific inquiry.

๐Ÿ’ผ Professional Endeavors

Currently serving as Deputy Chief Physician, Master’s Supervisor, and Lecturer at the First Affiliated Hospital of Nanjing Medical University, Dr. Cao is a dynamic force in clinical medicine and medical education. She is actively involved in mentoring graduate students while maintaining a busy clinical and research schedule.

๐Ÿ”ฌ Contributions and Research Focus On Hematologyย 

Dr. Cao’s research focuses on T-cell, B-cell, NK/T-cell, and Hodgkin lymphomas, with an emphasis on improving patient survival and quality of life through personalized medicine. She has led several national and institutional research projects, notably as Principal Investigator on prestigious grants such as the National Natural Science Foundation of China Youth Project and the Bethune Medical Science Research Foundation.

Her research outputs address topics like immunosuppressive microenvironments, hepatitis B reactivation in lymphoma patients, and novel chemotherapy strategies. She has authored multiple peer-reviewed SCI-indexed journal articles, furthering insights into the biology and treatment of hematologic malignancies.

๐ŸŒ Impact and Influence

Dr. Caoโ€™s work has directly contributed to clinical protocols, particularly in the treatment of indolent and relapsed lymphomas. Her clinical innovations and data-driven treatment strategies are helping to personalize therapies for patients across China. As a reviewer for journals such as Frontiers in Oncology and Cancer Medicine, she helps maintain the integrity of scientific research globally.

๐Ÿ“š Academic Citations

With a citation index of 419, her work demonstrates growing international recognition, showcasing the impact of her findings on clinical and academic communities alike.

๐Ÿ† Awards and Honors

Dr. Lei Caoโ€™s accolades include:

  • ๐Ÿฅ‡ First Prize, 2022 Jiangsu Anti-Cancer Association

  • ๐Ÿฅ‰ Third Prize, 2023 Clinical Research Innovation Award, Jiangsu Ruihua Charity Foundation

  • ๐ŸŒ Jiangsu Government Study Abroad Scholarships (2020 & 2023)

  • ๐Ÿ‘ฉโ€๐Ÿ”ฌ 2019 CSCO 35 Under 35 Most Promising Young Oncologist

  • ๐ŸŽ“ Multiple National Scholarships

๐Ÿงช Patents and Publications

  • ๐Ÿ“„ Patent: ZL202121517226.0 (National Utility Patent)

  • ๐Ÿ“ฐ Authored numerous high-impact publications in journals such as Blood Cancer Journal, British Journal of Haematology, Annals of Medicine, and Cancer Science.

๐Ÿ”ฎ Legacy and Future Contributions

Looking ahead, Dr. Lei Cao aims to refine stratification models, enhance targeted therapies, and further promote patient-centric care in hematologic malignancies. Her leadership, both in research and mentorship, continues to inspire a new generation of oncologists and researchers. Her future endeavors promise to deepen the scientific understanding of lymphoma biology and expand access to innovative treatments.

๐Ÿ“šPublications Top Notes

๐Ÿ“˜ Title: Stratified management based on surface antibody for the prevention of hepatitis B virus reactivation in lymphoma patients

๐Ÿ“š Journal: British Journal of Haematology
๐Ÿ“… Year: 2023
๐Ÿงช๐Ÿฉธ๐Ÿ›ก๏ธ (Oncology, Haematology, Immunity)

๐Ÿ“˜ Title: Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma

๐Ÿ“š Journal: Blood Cancer Journal
๐Ÿ“… Year: 2025
๐Ÿง ๐Ÿงฌ๐Ÿ’‰ (Oncology, Hematology, CNS)

 

Phetcharat Boonruamkaew | Neurophysiology | Best Researcher Award

Published on by Best Achievements

Dr. Phetcharat Boonruamkaew | Neurophysiology | Best Researcher Award

Dr. Phetcharat Boonruamkaew, School of Pharmacy/ Walailak University, Thailand.

๐ŸŽ“ Dr. Phetcharat Boonruamkaew is a Lecturer at the School of Pharmacy, with a Ph.D. in Physiology from Prince of Songkla University. Her expertise lies in neurophysiology, ๐Ÿง  oxidative stress, and neurodegenerative models. She has contributed significantly through her research, teaching, and international collaborations ๐Ÿ‡ฏ๐Ÿ‡ต. With multiple awards including the HEA Fellowship ๐Ÿ… and IBRO-SfN travel grants, Dr. Boonruamkaew continues to inspire in the field of neuroscience and pharmacology.๐Ÿ“˜๐ŸŒฟ

๐ŸŒŸ Professional Profile

๐Ÿง  Early Academic Pursuits

Dr. Phetcharat Boonruamkaewโ€™s academic journey reflects a deep-seated passion for biomedical sciences. ๐ŸŽ“ She began her higher education with a Bachelorโ€™s degree in Physical Therapy (Second Class Honor) from Walailak University in 2009. Her pursuit of anatomical and physiological knowledge continued with an M.Sc. in Anatomy from Mahidol University in 2012, and she achieved the pinnacle of academic qualification with a Ph.D. in Physiology from Prince of Songkla University in 2016. Her doctoral research excellence was later recognized as the Excellent Ph.D. Dissertation by the university.

๐Ÿ’ผ Professional Endeavors

Dr. Boonruamkaew currently serves as a Lecturer at the School of Pharmacy, where she has been an integral part since 2017. Her global outlook on research was further enriched during her time as a Researcher at the University of Tsukuba, Japan in 2015, contributing to cutting-edge studies in neurodegeneration and oxidative stress.

๐Ÿ”ฌ Contributions and Research Focus On Neurophysiologyย 

With a strong foundation in neurophysiology, Dr. Boonruamkaew’s expertise spans oxidative stress markers, and animal models of neurodegenerative disorders ๐Ÿงช. Her key research investigates the neuroprotective and pharmacological activities of natural extracts such as Passiflora edulis and Apium graveolens in mice models simulating Parkinsonโ€™s disease and Alzheimerโ€™s pathology. She has also pioneered work on antioxidative nanoparticles for treating amyloid plaque formation.

๐ŸŒ Impact and Influence

Her work has significantly impacted the fields of alternative medicine, neurodegeneration research, and antioxidant therapy. ๐Ÿ“Š Through innovative applications of plant-based compounds and nanoparticles, she has opened new avenues for therapeutic strategies in chronic neurodegenerative diseases. Dr. Boonruamkaewโ€™s research findings have been presented across prestigious global platforms in USA, Japan, Iran, Denmark, Malaysia, and India, enhancing international collaborations and scientific exchange.

๐Ÿ“š Academic Citations

Dr. Boonruamkaew has co-authored numerous peer-reviewed journal articles, including publications in Scientific Reports, BMC Complementary and Alternative Medicine, and Oxidative Medicine and Cellular Longevity. ๐Ÿงพ Her works, such as those exploring Apium graveolens and nanoparticle therapy, have contributed substantially to the academic discourse and are increasingly cited by fellow researchers worldwide.

๐Ÿ… Awards and Honors

Over the years, Dr. Boonruamkaew has garnered multiple prestigious recognitions, including:

  • Fellow of the Higher Education Academy (HEA), UK, 2019 ๐ŸŽ–๏ธ

  • IBRO-SfN Travel Grant, USA, 2017

  • Excellent Ph.D. Dissertation Award, 2016 ๐Ÿง‘โ€๐ŸŽ“

  • Multiple full-grant scholarships from IBRO-APRC to attend international neuroscience schools and conferences in Iran, Malaysia, and India between 2013โ€“2016.

๐Ÿ›๏ธ Legacy and Future Contributions

As an emerging leader in neuropharmacology and teaching, Dr. Boonruamkaewโ€™s academic legacy lies in her integrative approachโ€”combining natural medicine, oxidative stress modulation, and advanced drug delivery systems. ๐ŸŒฑ๐Ÿ”ฌ Her continued engagement in undergraduate education and scientific mentorship ensures a lasting impact on future generations of pharmacists and researchers. With ongoing contributions to both academia and biomedical research, she stands as a beacon of innovation and dedication in the Thai and global scientific communities.

๐Ÿ“šPublications Top Notes

  • ๐Ÿง  The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice
    ๐Ÿ“˜ BMC Complementary and Alternative Medicine
    ๐Ÿ“… 2018 | ๐Ÿ”ข Citations: 68

  • ๐Ÿงฌ Chronic treatment with a smart antioxidative nanoparticle for inhibition of amyloid plaque propagation in Tg2576 mouse model of Alzheimerโ€™s disease
    ๐Ÿ“˜ Scientific Reports
    ๐Ÿ“… 2017 | ๐Ÿ”ข Citations: 43

  • ๐Ÿ˜Š Apium graveolens extract influences mood and cognition in healthy mice
    ๐Ÿ“˜ Journal of Natural Medicines
    ๐Ÿ“… 2017 | ๐Ÿ”ข Citations: 32

  • ๐Ÿ˜Œ Anxiolytic and free radical scavenging potential of Chinese celery (Apium graveolens) extract in mice
    ๐Ÿ“˜ Asian Pacific Journal of Tropical Biomedicine
    ๐Ÿ“… 2017 | ๐Ÿ”ข Citations: 27

  • ๐Ÿ›ก๏ธ Redox Nanoparticle Therapeutics for Acetaminophenโ€Induced Hepatotoxicity in Mice
    ๐Ÿ“˜ Oxidative Medicine and Cellular Longevity
    ๐Ÿ“… 2016 | ๐Ÿ”ข Citations: 20
    (Note: This article appears twice, once under Boonruamkaew and once under B. Phetcharat, likely a co-authorship or metadata duplication.)

  • ๐Ÿฅฌ Celery
    ๐Ÿ“˜ Nutritional Composition and Antioxidant Properties of Fruits and Vegetables
    ๐Ÿ“… 2020 | ๐Ÿ”ข Citations: 6

Zhengyuan Feng | Computer Vision | Best Researcher Award

Published on by Best Achievements

Mr. Zhengyuan Feng | Computer Vision | Best Researcher Award

Mr. Zhengyuan Feng, Shanghai Dianji University, China.

Zhengyuan Feng ๐ŸŽ“ is a graduate student at Shanghai Dianji University, specializing in Computer Vision and Artificial Intelligence ๐Ÿค–. With strong skills in algorithms, programming, and system design, he developed a novel feature extraction method based on AGAST to enhance SLAM performance in weak-texture environments. Passionate about solving complex technical challenges, Zhengyuan is building a solid path toward future roles in technology R&D and engineering innovation ๐Ÿš€.

๐ŸŒŸ Professional Profile

ORCIDย 

๐Ÿง  Early Academic Pursuits

Zhengyuan Feng began his academic journey with a deep interest in computing and technology. As a student at Shanghai Dianji University, he embraced computer science with a focus on foundational areas such as algorithms, programming, and system design. These early interests laid the groundwork for his specialization in forward-looking disciplines, including artificial intelligence and machine learning. His academic growth has been marked by consistent exploration of emerging technologies and a drive to solve real-world problems through innovative engineering solutions.

๐Ÿ’ผ Professional Endeavors

Although still a student, Feng has demonstrated professional-caliber thinking through his hands-on research and engineering practice. His ability to independently develop and optimize systems reflects a strong alignment with roles typically reserved for experienced engineers in technology R&D. While he has not yet participated in formal industry collaborations or consultancy projects, his approach to problem-solving and design mirrors industry standards and practices.

๐Ÿ”ฌ Contributions and Research Focus On Computer Visionย ย 

Zhengyuan Fengโ€™s research centers on Computer Visionย and Artificial Intelligence, with a particular emphasis on Simultaneous Localization and Mapping (SLAM) systems. To overcome the limitations of traditional SLAM algorithms in weak-texture environments, he proposed two key innovations: an adaptive threshold feature extraction method based on AGAST and a multi-dimensional feature fusion-based loop closure detection algorithm. These techniques notably enhance the robustness and accuracy of SLAM performance under challenging conditions. His contributions reflect deep technical insight and creative application of AI methodologies to real-world computational challenges.

๐ŸŒ Impact and Influence

Although still early in his academic career, Fengโ€™s innovations promise meaningful improvements in fields that rely on robust SLAM systems, such as robotics, autonomous vehicles, and augmented reality. His work not only bridges the gap between theory and application but also sets the stage for future integration of adaptive AI techniques in embedded systems and navigation technologies.

๐Ÿ† Awards and Honors

While no formal awards have been listed in the current application, Zhengyuan Feng is seeking recognition through the Best Researcher Award. His application is a testament to the innovation and promise he brings as a graduate researcher. This nomination itself underscores the scholarly merit and relevance of his contributions to advanced computing.

๐Ÿ”ฎ Legacy and Future Contributions

Zhengyuan Feng is poised to become a key contributor in the evolution of intelligent systems. His trajectory suggests a future filled with academic publications, technological breakthroughs, and industry collaborations. As he moves forward, his focus will likely deepen on enhancing human-machine interaction, improving real-time decision-making systems, and pushing the boundaries of what artificial intelligence can achieve in dynamic environments.

๐Ÿ“šPublications Top Notes

Post-integration based point-line feature visual SLAM in low-texture environments

Scientific Reports, April 26, 2025
DOI: 10.1038/s41598-025-97250-6
Co-authors: Yanli Liu, Zhengyuan Feng, Heng Zhang, Wang Dong
Summary: This study introduces a novel visual SLAM approach that integrates point and line features to enhance performance in low-texture environments.

Abraham Teunissen | Immunology | Best Researcher Award

Published on by Best Achievements

Dr. Abraham Teunissen | Immunology | Best Researcher Award

Dr. Abraham Teunissen, Icahn school of medicine, United States.

Dr. Abraham J. P. Teunissen ๐ŸŽ“ is an Assistant Professor at the Biomedical Engineering and Imaging Institute, Icahn School of Medicine, New York ๐Ÿ—ฝ. He leads groundbreaking research in nanomedicine, radiochemistry, and immunotherapy ๐Ÿงฌ. With a Ph.D. in Molecular Engineering, he has authored high-impact studies and holds key patents. Dr. Teunissen mentors future scientists ๐Ÿ‘จโ€๐Ÿ”ฌ๐Ÿ‘ฉโ€๐Ÿ”ฌ and champions diversity and inclusion. His work on trained immunity and advanced imaging technologies is shaping the future of personalized medicine ๐ŸŒŸ.

๐ŸŒŸ Professional Profile

๐ŸŽ“Early Academic Pursuitsย 

Abraham J. P. Teunissen, Ph.D., embarked on his academic journey at Fontys University of Applied Science, earning a B.ASc in Organic Chemistry in 2011, where he developed supramolecular polymers for improved hemodialysis. He continued at Eindhoven University of Technology, securing an M.Sc. in Molecular Engineering (2013) and completing a Ph.D. (2017) focused on competing interactions in chemical reaction networks. His early research on biomimetic systems and chemical networks laid the foundation for a distinguished career in biomedical sciences.

๐ŸขProfessional Endeavorsย 

Dr. Teunissenโ€™s professional journey showcases a trajectory of growth and leadership. He held appointments at the prestigious Icahn School of Medicine at Mount Sinai, progressing from Postdoctoral Scientist (2017) to Instructor (2019), and ultimately to Assistant Professor (2022). He also serves as the Director of Radiochemistry at the Biomedical Engineering and Imaging Institute. Beyond academia, he consulted for Trained Therapeutix Discovery, driving translational innovation from 2019 to 2021.

๐Ÿ”ฌContributions and Research Focus On Immunologyย 

Dr. Teunissen has made notable contributions to nanomedicine, immunology, and molecular imaging. His research lab develops novel nanotherapies and imaging probes to modulate and monitor the immune system in various diseases โ€” including cancer, cardiovascular disease, diabetes, and organ transplantation. His teamโ€™s work spans small and large animal models, advancing therapeutic strategies with clinical relevance. His radiochemistry facility supports diverse collaborations, innovating nanoparticle tracking and immune monitoring using immuno-PET technology.

๐ŸŒŽImpact and Influenceย 

The outcomes of Dr. Teunissen’s research have wide-reaching impacts. His lab’s pioneering work on trained immunity modulation has driven forward collaborations, clinical translation efforts, and even the founding of a biotech company, Trained Therapeutix Discovery. His immuno-PET technologies enhance understanding of disease mechanisms and inform therapeutic interventions, demonstrating translational significance from bench to bedside.

๐Ÿ“šAcademic Cites and High-Impact Publicationsย 

Dr. Teunissen’s work has appeared in leading journals such as Cell, Nature Biomedical Engineering, Nature Nanotechnology, and Science Translational Medicine. His high citation count reflects the significance of his research, especially in trained immunity, nanomedicine, and molecular imaging fields. These citations highlight his contributions to both fundamental science and applied biomedical research.

๐Ÿ†Awards and Honorsย 

While specific individual awards were not detailed, Dr. Teunissen’s achievements include serving as an ad-hoc NIH and American Cancer Society grant reviewer, organizing major scientific symposia, and designing graduate-level coursework. His leadership roles โ€” like incident commander and scientific advisory organizer โ€” reflect high institutional trust and professional recognition.

๐Ÿ”ฎLegacy and Future Contributionsย 

Dr. Teunissenโ€™s legacy is rooted in scientific excellence, mentorship, and innovation. With an active lab mentoring a diverse group of postdocs, graduate, and premedical students, he is shaping the next generation of biomedical engineers and nanomedicine scientists. His future contributions are expected to further bridge fundamental science and clinical application, aiming to improve therapeutic outcomes for major diseases through immune modulation and advanced molecular imaging. His strong commitment to diversity, inclusion, and education ensures a lasting positive impact on both science and society.

๐Ÿ“šPublications Top Notes

  • Development of Methods for the Determination of pKa Values
    ๐Ÿ“ฐ Analytical Chemistry Insights | ๐Ÿ“‘ 483 citations | ๐Ÿ“… 2013

  • Investigating Supramolecular Systems Using Fรถrster Resonance Energy Transfer
    ๐Ÿ“ฐ Chemical Society Reviews | ๐Ÿ“‘ 159 citations | ๐Ÿ“… 2018

  • Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition
    ๐Ÿ“ฐ Cell | ๐Ÿ“‘ 145 citations | ๐Ÿ“… 2020

  • Efficacy and Safety Assessment of a TRAF6-Targeted Nanoimmunotherapy in Atherosclerotic Mice and Non-Human Primates
    ๐Ÿ“ฐ Nature Biomedical Engineering | ๐Ÿ“‘ 128 citations | ๐Ÿ“… 2018

  • End Groups of Functionalized Siloxane Oligomers Direct Block-Copolymeric or Liquid-Crystalline Self-Assembly Behavior
    ๐Ÿ“ฐ Journal of the American Chemical Society | ๐Ÿ“‘ 110 citations | ๐Ÿ“… 2016

  • Tumor Targeting by ฮฑvฮฒ3-Integrin-Specific Lipid Nanoparticles Occurs via Phagocyte Hitchhiking
    ๐Ÿ“ฐ ACS Nano | ๐Ÿ“‘ 93 citations | ๐Ÿ“… 2020

  • Directing the Selfโ€Assembly Behaviour of Porphyrinโ€Based Supramolecular Systems
    ๐Ÿ“ฐ Chemistry โ€“ A European Journal | ๐Ÿ“‘ 82 citations | ๐Ÿ“… 2017

  • Imaging-Assisted Nanoimmunotherapy for Atherosclerosis in Multiple Species
    ๐Ÿ“ฐ Science Translational Medicine | ๐Ÿ“‘ 68 citations | ๐Ÿ“… 2019

  • Prosaposin Mediates Inflammation in Atherosclerosis
    ๐Ÿ“ฐ Science Translational Medicine | ๐Ÿ“‘ 65 citations | ๐Ÿ“… 2021

  • Nuclear Imaging Approaches Facilitating Nanomedicine Translation
    ๐Ÿ“ฐ Advanced Drug Delivery Reviews | ๐Ÿ“‘ 63 citations | ๐Ÿ“… 2020

  • Probing Myeloid Cell Dynamics in Ischaemic Heart Disease by Nanotracer Hot-Spot Imaging
    ๐Ÿ“ฐ Nature Nanotechnology | ๐Ÿ“‘ 61 citations | ๐Ÿ“… 2020

  • Mechanically Induced Gelation of a Kinetically Trapped Supramolecular Polymer
    ๐Ÿ“ฐ Macromolecules | ๐Ÿ“‘ 52 citations | ๐Ÿ“… 2014

  • Imaging Cardiovascular and Lung Macrophages with the Positron Emission Tomography Sensor 64Cu-Macrin in Mice, Rabbits, and Pigs
    ๐Ÿ“ฐ Circulation: Cardiovascular Imaging | ๐Ÿ“‘ 44 citations | ๐Ÿ“… 2020

  • Resolving Sepsis-Induced Immunoparalysis via Trained Immunity by Targeting Interleukin-4 to Myeloid Cells
    ๐Ÿ“ฐ Nature Biomedical Engineering | ๐Ÿ“‘ 37 citations | ๐Ÿ“… 2023

  • A Modular Approach Toward Producing Nanotherapeutics Targeting the Innate Immune System
    ๐Ÿ“ฐ Science Advances | ๐Ÿ“‘ 35 citations | ๐Ÿ“… 2021

  • An Iterative Sparse Deconvolution Method for Simultaneous Multicolor 19Fโ€MRI of Multiple Contrast Agents
    ๐Ÿ“ฐ Magnetic Resonance in Medicine | ๐Ÿ“‘ 30 citations | ๐Ÿ“… 2020

ย 

Chengqun Xu | Environmental | Best Researcher Award

Published on by Best Achievements

Dr. Chengqun Xu | Environmental | Best Researcher Award

Dr. Chengqun Xu, Wuyi University, China.

Dr. Chengqun Xu ๐ŸŽ“ is an Associate Professor at the School of Applied Physics and Materials, Wuyi University. He earned his Ph.D. in Physical Chemistry from South China University of Technology. His research focuses on photocatalysis, materials nanoarchitectonics, and green energy technologies ๐ŸŒฑ. With multiple first-author publications in top-tier journals, he is recognized for his innovation and leadership in advanced materials science ๐Ÿ”ฌ. Dr. Xu continues to make significant strides in sustainable research for global impact ๐ŸŒ.

๐ŸŒŸ Professional Profile

Scopus Profile

๐ŸŽ“ Early Academic Pursuits

Dr. Chengqun Xu embarked on his academic journey with a Bachelorโ€™s degree in Chemistry ๐ŸŽ“ from Anqing Normal University (2007โ€“2011). Driven by a passion for deep scientific exploration, he pursued a Masterโ€™s degree in Physical Chemistry ๐Ÿ”ฌ at South China Normal University (2012โ€“2015). Eager to further sharpen his research capabilities, Xu then earned his Ph.D. in Physical Chemistry ๐Ÿงช from South China University of Technology (2015โ€“2018), laying a strong foundation for his future academic and research career.

๐Ÿ’ผ Professional Endeavors

Dr. Chengqun Xu began his career as a Lecturer ๐Ÿ‘จโ€๐Ÿซ at the School of Applied Physics and Materials, Wuyi University (2019โ€“2023). His outstanding contributions and commitment to academia led to his promotion as an Associate Professor ๐Ÿ“š in 2023 at the same institution. Additionally, he expanded his global experience by working at the International Center for Materials Nanoarchitectonics (NIMS), Japan ๐Ÿ‡ฏ๐Ÿ‡ต during two distinct periods (2017โ€“2018 and 2023โ€“2024), engaging in advanced international collaborations.

๐Ÿ”ฌ Contributions and Research Focus On Environmentalย 

Dr. Xu’s research primarily revolves around photocatalytic materials, molecular engineering, and carbon nitride-based systems โ˜€๏ธ๐Ÿงฌ. His focus is on enhancing photocatalytic hydrogen production, optimizing ฯ€-delocalization in g-Cโ‚ƒNโ‚„, and developing direct Z-scheme photocatalytic systems. His projects delve into green light-driven catalysis and visible-light hydrogen evolution, aiming to solve global energy challenges sustainably ๐ŸŒŽ.

๐ŸŒ Impact and Influence

Through his innovative work, Chengqun Xu has significantly impacted the field of environmental catalysis and renewable energy materials ๐Ÿ”ฅโ™ป๏ธ. His advanced engineering of photocatalysts has set new benchmarks for efficiency, promoting cleaner energy generation and inspiring further research into sustainable technologies among peers and future scientists.

๐Ÿ† Awards and Honors

Dr. Chengqun Xu successfully completed the Guangdong Basic and Applied Basic Research Foundation Regional Joint Youth Fund Project ๐ŸŒŸ, where he served as Principal Investigator. His outstanding project on regulating conjugation effects in g-Cโ‚ƒNโ‚„ molecular structures received funding of 100,000 RMB, recognizing his pioneering contribution to molecular photocatalysis research.

๐Ÿ“ŠAcademic Cites

Dr. Xuโ€™s research excellence is reflected in his publications in prestigious journals such as Applied Catalysis B: Environmental, Chemical Engineering Journal, ACS Applied Materials & Interfaces, and Journal of Materials Chemistry A ๐Ÿ“–โœจ. His role as sole first author in multiple high-impact papers underlines his leadership in his field. His works continue to garner citations and influence researchers worldwide.

๐Ÿš€ Legacy and Future Contributions

Dr. Chengqun Xuโ€™s legacy lies in his molecular-level innovations for sustainable energy โšก. As he continues his journey, Xu is poised to lead groundbreaking research projects, contribute to more international collaborations ๐ŸŒ, and mentor the next generation of researchers. His work promises to pave the way for future technologies that bridge chemistry, materials science, and environmental sustainability.

๐Ÿ“šPublications Top Notesย 

๐Ÿ“„ Title: Molten-salt assisted synthesis of polymeric carbon nitride-based photocatalyst for enhanced photocatalytic activity under green light irradiation
๐Ÿ‘ฅ Authors: Chengqun Xu; Haiyang Liu; Dongyu Wang; Dezhi Li; Ying Zhang; Xiaolu Liu; Jingyao Huang; Shengquan Wu; Donghua Fan; Hongguang Liu; Hui Pan
๐Ÿ“ฐ Journal: Applied Catalysis B: Environmental
๐Ÿ“… Year: 2023

๐Ÿ“„ Title: Direct Z-scheme construction of g-Cโ‚ƒNโ‚„ quantum dots/TiOโ‚‚ nanoflakes for efficient photocatalysis
๐Ÿ‘ฅ Authors: Chengqun Xu; Dezhi Li; Xiaolu Liu; Renzhi Ma; Nobuyuki Sakai; Yuchen Yang; Shiyin Lin; Jiale Yang; Hui Pan; Janjer Huang; Takayoshi Sasaki
๐Ÿ“ฐ Journal: Chemical Engineering Journal
๐Ÿ“… Year: 2021

๐Ÿ“„ Title: Coordination of ฯ€-Delocalization in g-Cโ‚ƒNโ‚„ for Efficient Photocatalytic Hydrogen Evolution under Visible Light
๐Ÿ‘ฅ Authors: Chengqun Xu; Xiaolu Liu; Dezhi Li; Zeyuan Chen; Jiale Yang; Janjer Huang; Hui Pan
๐Ÿ“ฐ Journal: ACS Applied Materials & Interfaces
๐Ÿ“… Year: 2021

๐Ÿ“„ Title: Molecular engineering for constructing a Dโ€“A system and enhancing delocalization in g-Cโ‚ƒNโ‚„ with superior photocatalytic activity
๐Ÿ‘ฅ Authors: Chengqun Xu; Xiaolu Liu; Haiyang Liu; Dezhi Li; Yuchen Yang; Shiyin Lin; Donghua Fan; Hui Pan
๐Ÿ“ฐ Journal: Journal of Materials Chemistry A
๐Ÿ“… Year: 2022

๐Ÿ“„ Title: Molecular engineering of polymeric carbon nitride for photocatalytic hydrogen production with ultrahigh apparent quantum efficiency
๐Ÿ‘ฅ Authors: Haiyang Liu; Xiaolu Liu; Chengqun Xu; Dongyu Wang; Dezhi Li; Jingyao Huang; Shengquan Wu; Zhichun Wang; Hui Pan
๐Ÿ“ฐ Journal: Journal of Materials Chemistry A
๐Ÿ“… Year: 2024

๐Ÿ“„ Title: Molecular doping and molten-salt-assisted synthesis for a highly efficient polymeric carbon nitride-based photocatalyst with broad-spectrum optical responsiveness
๐Ÿ‘ฅ Authors: H. Liu, Yifan Chen, Chengqun Xu, Donghua Fan, Jinhua Ye
๐Ÿ“ฐ Journal: Journal of Alloys and Compounds
๐Ÿ“… Year: 2025

 

Adem MelekoฤŸlu | Cardiovascular | Academic Research and Development Award

Published on by Best Achievements

Dr. Adem MelekoฤŸlu | Cardiovascular | Academic Research and Development Award

Dr. Adem MelekoฤŸlu, ลžiลŸli Hamiiye Etfal Trining and Research Hospital, Turkey.

Dr. Adem MelekoฤŸlu ๐ŸŽ“ is an Emergency Medicine Specialist at ลžiลŸli Hamidiye Etfal Training and Research Hospital, Turkey. With a medical degree from Cukurova University and a doctoral specialization in Emergency Medicine, he has made impactful contributions through extensive clinical research ๐Ÿ”ฌ, focusing on acute care, cardiovascular emergencies, and COVID-19. Dr. MelekoฤŸlu has actively participated in national and international congresses ๐ŸŽค, sharing valuable insights. His commitment to academic research and development makes him a distinguished figure in emergency medicine ๐Ÿš‘.

๐ŸŒŸ Professional Profile

๐ŸŽ“ Early Academic Pursuits

Dr. Adem MelekoฤŸlu began his medical journey with a solid academic foundation at ร‡ukurova University, where he earned his medical degree in 2011. Demonstrating a strong passion for emergency care, he advanced his studies at Ankara DฤฑลŸkapฤฑ Yฤฑldฤฑrฤฑm Beyazฤฑt Training and Research Hospital, completing his doctoral specialization in Emergency Medicine in 2016. His early education laid the groundwork for a focused and impactful career in clinical medicine and research.

๐Ÿ’ผ Professional Endeavors

Since 2016, Dr. MelekoฤŸlu has been serving as an Emergency Medicine Specialist at the ลžiลŸli Hamidiye Etfal Training and Research Hospital under the Health Sciences University of Turkey. His role involves not only patient care in critical situations but also training, mentoring, and contributing to the development of emergency medical protocols and responses.

๐Ÿ”ฌ Contributions and Research Focus On Cardiovascularย 

Dr. MelekoฤŸlu has actively contributed to the evolving body of emergency medicine with a distinct focus on cardiovascular emergencies, COVID-19-related complications, toxicology, and respiratory disorders like COPD. His research portfolio includes over 20 clinical trials and case studies, where he has served as a responsible researcher, co-researcher, or instructor, reflecting his versatility in both clinical and academic settings. From investigating the efficacy of Esmolol and Nicardipine in ischemic stroke to exploring biomarkers in COVID-19, his work bridges critical gaps in real-time emergency care.

๐ŸŒ Impact and Influence

Dr. MelekoฤŸlu’s research has been presented at leading national and international platforms, including the International Emergency Medicine Congress, Eurasian Congress on Emergency Medicine, and Young Academy of Cardiovascular Congress. His findings have enriched clinical understanding and influenced treatment strategies, particularly in emergency management of acute pulmonary embolism, ischemic strokes, and COVID-related cardiac issues.

๐Ÿ† Awards and Honors

Among the notable recognitions is his oral presentation at the 3rd International Emergency Medicine Congress (2023) on COPD Emergency Admissions, marking his presence as a scholarly voice in acute care research. His continuous involvement as a conference speaker and instructor further underscores his status in the academic community.

๐Ÿ“ŠAcademic Citations

While exact citation numbers are pending, the diversity and relevance of his studies suggest a growing academic footprint. His collaborative roles in widely referenced case reports and observational studies contribute to the expanding repository of emergency care literature in Turkey and globally.

๐Ÿš€ Legacy and Future Contributions

With a career rooted in dedication, innovation, and lifesaving interventions, Dr. Adem MelekoฤŸlu is poised to make enduring contributions to emergency medicine. His work not only saves lives but also educates future generations of emergency physicians. Looking ahead, his commitment to exploring inflammation indexes, clinical biomarkers, and innovative treatment protocols positions him as a forward-thinking leader in medical science.

๐Ÿ“šPublications Top Notesย 

๐Ÿงช Comparison of Esmolol and Nicardipine Treatment in Hypertensive Acute Ischemic Stroke Patients
Journal: Scientific Reports
Year: 2025
DOI: 10.1038/s41598-025-98699-1

๐Ÿ’“ Relationship Between Shock Index, sPESI Score, and Right Ventricular Dysfunction in CTPA with Mortality in Patients Diagnosed with Acute PTE in the Emergency Department
Journal: Journal of Academic Research in Medicine
Year: 2023
DOI: 10.4274/jarem.galenos.2023.16769

๐Ÿฆ  Serum Endocan Levels as A Valuable Biomarker for Discrimination of Critical and Stable COVID-19 Patients
Journal: Bagcilar Medical Bulletin
Year: 2023
DOI: 10.4274/BMB.galenos.2023.2022-10-083

๐Ÿงฌ Evaluation of Laboratory Findings for Treating Acute Ischemic Stroke
Journal: Global Emergency and Critical Care
Year: 2023
DOI: 10.4274/globecc.galenos.2023.57966

๐Ÿฉธ Relationship Between Hematological Parameters and Mortality in Patients with Acute PTE
Journal: Global Emergency and Critical Care
Year: 2023
DOI: 10.4274/globecc.galenos.2023.00719

๐ŸŒฌ๏ธ Clinical Evaluation of Chronic Obstructive Pulmonary Disease Patients Hospitalized with COVID-19 Pneumonia
Journal: Indian Journal of Respiratory Care
Year: 2023
DOI: 10.5005/jp-journals-11010-1006

Kishalay Paria | Environmental Biotechnology | Best Researcher Award

Published on by Best Achievements

Dr. Kishalay Paria | Environmental Biotechnology | Best Researcher Award

Dr. Kishalay Paria, Vidyasagar University, India.

๐Ÿงฌ Dr. Kishalay Paria is an accomplished Assistant Professor of Microbiology at Vidyasagar University, India. A former Bentham Ambassador, he holds a Ph.D. in Biotechnology with a focus on fungal bioremediation. Dr. Paria has published extensively in high-impact journals like Chemosphere and BMC Chemistry ๐Ÿ“š. With numerous awards including Young Achiever (InSc) and Best Poster recognitions, his work bridges ecological microbiology and sustainable technologies ๐ŸŒฑ. He also contributes significantly as an educator and research mentor.

๐ŸŒŸ Professional Profile

R LAKSHMI | CIVIL ENGINEERING | BEST RESEARCH AWARD

Published on by Best Achievements

Dr. R LAKSHMI | CIVIL ENGINEERING | BEST RESEARCH AWARD

Dr. R LAKSHMI, KARPAGAM COLLEGE OF ENGINEERING, INDIA.

๐Ÿ”ฌ Dr. R. Lakshmi is a distinguished Civil Engineering academician with 26 years of teaching and industry experience. She earned her PhD from Anna University, specializing in โ™ป๏ธ E-waste management in construction. Her research covers water conservation, special concretes, and structural health monitoring. With 44+ publications, she is a recognized contributor to sustainable engineering. ๐Ÿ† She has received the Outstanding Women Researcher Award and actively collaborates with ACCE, ICI, IEI, and other professional bodies to bridge research with real-world impact. ๐Ÿ—๏ธ

๐ŸŒŸ Professional Profile

๐ŸŽ“ Early Academic Pursuits

Dr. R. Lakshmi began her academic journey in the field of Civil Engineering with a B.E. degree from the Government College of Engineering, Tirunelveli. Passionate about structural integrity and design, she further pursued an M.E. in Structural Engineering from the prestigious Thiagarajar College of Engineering, Madurai. Her academic path reached its zenith with a PhD from Anna University, Chennai, where she explored Electronic Waste Management through Construction Practices, marking a unique intersection of sustainability and engineering. ๐ŸŽ“๐Ÿ“˜

๐Ÿ’ผ Professional Endeavors

With an impressive 26 years of teaching and industry experience, Dr. Lakshmi has cultivated a well-rounded professional identity. She has played a vital role in both academia and consultancy, bringing real-world structural solutions into the classroom and vice versa. Her expertise is routinely sought in Structural Design, Concrete Mix Design, Soil Testing, and Total Station Surveying. ๐Ÿ—๏ธ๐Ÿ“

๐Ÿ”ฌ Contributions and Research Focus On Civil Engineering

Dr. Lakshmi’s core research focuses on Environmental Sustainability in construction. Her topics of interest span across Conservation of Water Resources, Plastic and E-Waste Management, Environmental Impact Assessment, Special Concretes, and Structural Health Monitoring. She has published 44 technical papers in reputed international journals and conferences, strengthening the bridge between engineering and environmental care. ๐ŸŒฑ๐Ÿงช๐Ÿ“„

๐ŸŒ Impact and Influence

Dr. Lakshmiโ€™s influence extends beyond academic walls. Her consultancy projects and consistent collaboration with professional bodies like the Association of Consulting Civil Engineers (ACCE), Indian Concrete Institute (ICI), Institution of Engineers (IEI), and NAWAD Tech Mission have had significant practical impacts. Her work reflects a strong commitment to sustainable development and industry innovation. ๐Ÿค๐ŸŒ

๐Ÿ† Awards and Honors

Dr. Lakshmi has received numerous accolades recognizing her excellence in research and professional practice. Notably, she was the Coordinator for the Best Infrastructure Award by ICI Madurai Centre and Ultra Tech Cement Limited (2021). She is also the proud recipient of the Outstanding Women Researcher Award from Venus International Research Foundation, and she triumphed in the High Strength Concrete Cube Competition conducted by ACCE. ๐Ÿ†๐Ÿฅ‡๐ŸŒŸ

๐Ÿ“ŠAcademic Citations

With her substantial research contributions and technical publications, Dr. Lakshmi has garnered significant academic attention. Her work is frequently cited in the fields of sustainable construction practices and structural engineering, contributing to the global discourse on eco-friendly infrastructure development. ๐Ÿ“š๐Ÿ”

๐Ÿš€ Legacy and Future Contributions

As a Board of Studies Member at Anna University and Executive Member of NAWAD Tech Mission, Dr. Lakshmi continues to influence curriculum development and technical innovation. Her legacy is rooted in a balanced blend of academia, industry relevance, and environmental consciousness. Looking ahead, she is dedicated to mentoring future engineers and pioneering sustainable solutions in civil engineering. ๐Ÿ”ง๐Ÿ“ˆ๐ŸŒ

๐Ÿ“šPublications Top Notes

๐Ÿ“˜ Studies on concrete containing E plastic waste

Authors: R. Lakshmi, S. Nagan
Journal: International Journal of Environmental Sciences, Vol. 1(3), pp. 270โ€“281
Cited by: 103 | Year: 2010
๐Ÿ“ฆโ™ป๏ธ Focus: Sustainable concrete using e-waste plastic materials

๐Ÿ—๏ธ Investigations on durability characteristics of E-plastic waste incorporated concrete

Authors: R. Lakshmi, S. Nagan
Journal: Asian Journal of Civil Engineering (Building and Housing), Vol. 12(6), pp. 773โ€“787
Cited by: 87 | Year: 2011
๐Ÿงฑ๐ŸŒ Focus: Long-term performance of plastic waste-infused concrete

๐Ÿงช Utilization of waste E plastic particles in cementitious mixtures

Authors: R. Lakshmi, S. Nagan
Journal: Journal of Structural Engineering, Vol. 38(1), pp. 26โ€“35
Cited by: 53 | Year: 2011
๐Ÿ˜๏ธโ™ป๏ธ Focus: Incorporating electronic plastic waste in cement-based composites

๐ŸŒ Detection of legitimate and phishing websites using machine learning

Authors: A. Bhavani, R.S. Lakshmi, P. Harshavardhini, P.V. Prakash, N.V. Behara, …
Conference: 2023 International Conference on Sustainable Computing and Smart Systems (SUSCOM)
Cited by: 4 | Year: 2023
๐Ÿค–๐Ÿ”’ Focus: Cybersecurity and machine learning applications

๐Ÿงฌ Comparative Study on the Strength Behavior of Self-Healing Concrete Using Silica Gel and Bacteria as Healing Agents

Authors: L. Radhakumar, S. Murugan, J. Sankaralingam
Journal: Journal of Materials in Civil Engineering, Vol. 35(12), 04023483
Cited by: 3 | Year: 2023
๐Ÿงฑ๐Ÿฆ  Focus: Innovative self-healing concrete technologies

โ„๏ธ Passive Cooling of Building using Glycerine and Paraffin Wax with Perlite as Phase Changing Materials

Authors: P. AIM Kathirvel, R. Lakshmi, P. S. Poorna Prakash
Journal: International Journal of Engineering Research & Technology, Vol. 9(4), pp. 811โ€“815
Cited by: 1 | Year: 2020
๐Ÿ ๐ŸŒก๏ธ Focus: Energy-efficient building materials

๐Ÿ”ฌ Influence of Nano Silica and Metakaolin on the Strength and Durability Properties of Geopolymer Concrete

Authors: R. Lakshmi, P. Kathirvel, E. Sakthivel, R.M. Suburam
Journal: Iranian Journal of Science and Technology, Transactions of Civil Engineering
Year: 2025
๐Ÿงฑ๐Ÿ”ง Focus: High-performance sustainable concrete materials

โ™ป๏ธ Sustainable waste management options of waste plastic particles in cementitious mixtures for mass concrete applications

Authors: R. Lakshmi, R. Sowmiyavalli, K. Arunprasath, T. Rajpradeesh
Journal: Interactions, Vol. 245(1), p. 340
Year: 2024
๐Ÿ—๏ธโ™ป๏ธ Focus: Circular economy approach in mass construction

๐Ÿญ Utilising Recycled Plastic Waste in Cementitious Materials for Sustainable Waste Management in Large-Scale Concrete Applications

Authors: R. S. M. Lakshmi
Journal: Industrial Engineering Journal, Vol. 53(4), pp. 33โ€“45
Year: 2024
๐Ÿข๐ŸŒฟ Focus: Industrial-scale applications of recycled plastics in construction

๐Ÿงฑ Performance of Novel Magnesium Phosphate Cement Using Sodium Dihydrogen Phosphate

Authors: P. Kathirvel, R. Lakshmi, J. Jacob
Book: Advances in Construction Materials and Structures: Select Proceedings
Year: 2021
๐Ÿงช๐Ÿงฑ Focus: Innovative binders for construction

 

Kajal Gautam | Plant nanobionics | Best Researcher Award

Published on by Best Achievements

Ms. Kajal Gautam | Plant nanobionics | Best Researcher Award

Ms. Kajal Gautam, UPES, India.

Ms. Kajal Gautam is a PhD Scholar in Applied Sciences at UPES Dehradun ๐Ÿงช๐ŸŒฟ, specializing in the sustainable synthesis of nano-biomaterials for plant nanobionics. With hands-on research at CSIR-NIO, Manav Rachna University, and the University of Delhi, she brings a strong background in green chemistry and nanotechnology. She holds an M.Sc. in Chemistry (92.9%) and has won the Best Oral Presentation Award (2022) ๐Ÿ†. Her work blends innovation, sustainability, and plant science for a greener future. ๐Ÿƒโš—๏ธ

๐ŸŒŸ Professional Profile